By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


PROLOR Biotech 

Weizmann Science Park
3 Sapir Street
Nes Ziona    74140  Israel
Phone: 866-644-7811 Fax: 972-8-9300091


Company News
Opko Health, Inc. Announces Dismissal Of PROLOR Biotech (PBTH) Class Action Lawsuit 5/8/2014 12:51:55 PM
Opko Health, Inc. Completes Acquisition of PROLOR Biotech (PBTH) 8/29/2013 11:13:09 AM
PROLOR Biotech (PBTH) to Present Positive Results From Preclinical Studies of Long-Acting Clotting Factor VIIa-CTP at ISTH 2013 7/3/2013 6:53:39 AM
PROLOR Biotech (PBTH) to Present New Data on its Long-Acting Human Growth Hormone and Long-Acting Oxyntomodulin at ENDO 2013 6/13/2013 6:22:00 AM
PROLOR Biotech (PBTH) Initiates Pivotal Phase III Trial Of Its Longer-Acting Version Of Human Growth Hormone 6/4/2013 9:16:30 AM
PROLOR Biotech (PBTH) to Present at Jefferies and Co. 2013 Global Healthcare Conference 5/31/2013 6:37:39 AM
Opko Health, Inc. Acquires PROLOR Biotech (PBTH) for $480 Million 4/24/2013 7:37:46 AM
PROLOR Biotech (PBTH) Receives Notice of Allowance For New U.S. Patent Covering Long-Acting Coagulation Factors VII and IX 4/8/2013 10:13:03 AM
PROLOR Biotech (PBTH) Receives Notice of Allowance for New U.S. Patent Covering Methods for Decreasing Body Fat With hGH-CTP 3/5/2013 10:02:01 AM
PROLOR Biotech (PBTH)'s Longer-Acting Human Growth Hormone Receives Orphan Drug Designation in Europe 2/13/2013 9:13:15 AM